nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Melatonin—CALM3—ulcerative colitis	0.03	0.741	CrCbGaD
Midodrine—Melatonin—MPO—ulcerative colitis	0.0105	0.259	CrCbGaD
Midodrine—Pain—Nicotine—ulcerative colitis	0.00379	0.00446	CcSEcCtD
Midodrine—Mental disorder—Budesonide—ulcerative colitis	0.00376	0.00443	CcSEcCtD
Midodrine—Flatulence—Budesonide—ulcerative colitis	0.00368	0.00434	CcSEcCtD
Midodrine—Hepatobiliary disease—Mesalazine—ulcerative colitis	0.00368	0.00433	CcSEcCtD
Midodrine—Tension—Budesonide—ulcerative colitis	0.00367	0.00432	CcSEcCtD
Midodrine—Feeling abnormal—Nicotine—ulcerative colitis	0.00365	0.0043	CcSEcCtD
Midodrine—Nervousness—Budesonide—ulcerative colitis	0.00363	0.00428	CcSEcCtD
Midodrine—Erythema multiforme—Azathioprine—ulcerative colitis	0.00362	0.00427	CcSEcCtD
Midodrine—Gastrointestinal pain—Nicotine—ulcerative colitis	0.00362	0.00427	CcSEcCtD
Midodrine—Back pain—Budesonide—ulcerative colitis	0.00361	0.00426	CcSEcCtD
Midodrine—Muscle spasms—Budesonide—ulcerative colitis	0.00359	0.00423	CcSEcCtD
Midodrine—Abdominal pain—Nicotine—ulcerative colitis	0.0035	0.00412	CcSEcCtD
Midodrine—Urinary tract disorder—Mesalazine—ulcerative colitis	0.00345	0.00406	CcSEcCtD
Midodrine—Chills—Azathioprine—ulcerative colitis	0.00344	0.00405	CcSEcCtD
Midodrine—Agitation—Budesonide—ulcerative colitis	0.00343	0.00404	CcSEcCtD
Midodrine—Irritability—Hydrocortisone—ulcerative colitis	0.00343	0.00403	CcSEcCtD
Midodrine—Urethral disorder—Mesalazine—ulcerative colitis	0.00342	0.00403	CcSEcCtD
Midodrine—Dry skin—Prednisolone—ulcerative colitis	0.00337	0.00397	CcSEcCtD
Midodrine—Erythema multiforme—Mesalazine—ulcerative colitis	0.0033	0.00389	CcSEcCtD
Midodrine—Dry skin—Hydrocortisone—ulcerative colitis	0.00329	0.00387	CcSEcCtD
Midodrine—Cardiac disorder—Mesalazine—ulcerative colitis	0.00324	0.00382	CcSEcCtD
Midodrine—Hypertension—Budesonide—ulcerative colitis	0.00323	0.0038	CcSEcCtD
Midodrine—Irritability—Methylprednisolone—ulcerative colitis	0.00322	0.00379	CcSEcCtD
Midodrine—Asthenia—Nicotine—ulcerative colitis	0.00318	0.00374	CcSEcCtD
Midodrine—Anxiety—Budesonide—ulcerative colitis	0.00317	0.00373	CcSEcCtD
Midodrine—Angiopathy—Mesalazine—ulcerative colitis	0.00317	0.00373	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.00316	0.00372	CcSEcCtD
Midodrine—Pruritus—Nicotine—ulcerative colitis	0.00313	0.00369	CcSEcCtD
Midodrine—Chills—Mesalazine—ulcerative colitis	0.00313	0.00369	CcSEcCtD
Midodrine—Dry mouth—Budesonide—ulcerative colitis	0.00311	0.00366	CcSEcCtD
Midodrine—Confusional state—Budesonide—ulcerative colitis	0.00308	0.00362	CcSEcCtD
Midodrine—Mental disorder—Mesalazine—ulcerative colitis	0.00306	0.0036	CcSEcCtD
Midodrine—Flatulence—Mesalazine—ulcerative colitis	0.00299	0.00353	CcSEcCtD
Midodrine—Nervous system disorder—Budesonide—ulcerative colitis	0.00299	0.00352	CcSEcCtD
Midodrine—Tension—Mesalazine—ulcerative colitis	0.00298	0.00351	CcSEcCtD
Midodrine—Tachycardia—Budesonide—ulcerative colitis	0.00298	0.00351	CcSEcCtD
Midodrine—Skin disorder—Budesonide—ulcerative colitis	0.00296	0.00349	CcSEcCtD
Midodrine—Nervousness—Mesalazine—ulcerative colitis	0.00295	0.00348	CcSEcCtD
Midodrine—Back pain—Mesalazine—ulcerative colitis	0.00294	0.00346	CcSEcCtD
Midodrine—Dizziness—Nicotine—ulcerative colitis	0.00293	0.00345	CcSEcCtD
Midodrine—Irritability—Dexamethasone—ulcerative colitis	0.00293	0.00345	CcSEcCtD
Midodrine—Irritability—Betamethasone—ulcerative colitis	0.00293	0.00345	CcSEcCtD
Midodrine—Muscle spasms—Mesalazine—ulcerative colitis	0.00292	0.00344	CcSEcCtD
Midodrine—Rash—Mercaptopurine—ulcerative colitis	0.00288	0.00339	CcSEcCtD
Midodrine—Dermatitis—Mercaptopurine—ulcerative colitis	0.00288	0.00339	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.00282	0.00332	CcSEcCtD
Midodrine—Dry skin—Betamethasone—ulcerative colitis	0.00281	0.00331	CcSEcCtD
Midodrine—Dry skin—Dexamethasone—ulcerative colitis	0.00281	0.00331	CcSEcCtD
Midodrine—Rash—Nicotine—ulcerative colitis	0.00279	0.00329	CcSEcCtD
Midodrine—Dermatitis—Nicotine—ulcerative colitis	0.00279	0.00329	CcSEcCtD
Midodrine—Headache—Nicotine—ulcerative colitis	0.00277	0.00327	CcSEcCtD
Midodrine—Insomnia—Budesonide—ulcerative colitis	0.00276	0.00325	CcSEcCtD
Midodrine—Paraesthesia—Budesonide—ulcerative colitis	0.00274	0.00323	CcSEcCtD
Midodrine—Dyspnoea—Budesonide—ulcerative colitis	0.00272	0.0032	CcSEcCtD
Midodrine—Nausea—Mercaptopurine—ulcerative colitis	0.00271	0.0032	CcSEcCtD
Midodrine—Somnolence—Budesonide—ulcerative colitis	0.00271	0.00319	CcSEcCtD
Midodrine—Dyspepsia—Budesonide—ulcerative colitis	0.00268	0.00316	CcSEcCtD
Midodrine—Skin disorder—Azathioprine—ulcerative colitis	0.00264	0.00312	CcSEcCtD
Midodrine—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00263	0.0031	CcSEcCtD
Midodrine—Nausea—Nicotine—ulcerative colitis	0.00263	0.0031	CcSEcCtD
Midodrine—Hypertension—Mesalazine—ulcerative colitis	0.00262	0.00309	CcSEcCtD
Midodrine—Pain—Budesonide—ulcerative colitis	0.00261	0.00307	CcSEcCtD
Midodrine—Bradycardia—Prednisolone—ulcerative colitis	0.00259	0.00305	CcSEcCtD
Midodrine—Anxiety—Mesalazine—ulcerative colitis	0.00258	0.00304	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00257	0.00303	CcSEcCtD
Midodrine—Irritability—Prednisone—ulcerative colitis	0.00255	0.003	CcSEcCtD
Midodrine—Dry mouth—Mesalazine—ulcerative colitis	0.00253	0.00298	CcSEcCtD
Midodrine—Bradycardia—Hydrocortisone—ulcerative colitis	0.00253	0.00298	CcSEcCtD
Midodrine—Feeling abnormal—Budesonide—ulcerative colitis	0.00251	0.00296	CcSEcCtD
Midodrine—Confusional state—Mesalazine—ulcerative colitis	0.0025	0.00295	CcSEcCtD
Midodrine—Gastrointestinal pain—Budesonide—ulcerative colitis	0.00249	0.00294	CcSEcCtD
Midodrine—Dry skin—Prednisone—ulcerative colitis	0.00245	0.00288	CcSEcCtD
Midodrine—Nervous system disorder—Mesalazine—ulcerative colitis	0.00243	0.00287	CcSEcCtD
Midodrine—Tachycardia—Mesalazine—ulcerative colitis	0.00242	0.00285	CcSEcCtD
Midodrine—Abdominal pain—Budesonide—ulcerative colitis	0.00241	0.00284	CcSEcCtD
Midodrine—Skin disorder—Mesalazine—ulcerative colitis	0.00241	0.00284	CcSEcCtD
Midodrine—Bradycardia—Triamcinolone—ulcerative colitis	0.00238	0.0028	CcSEcCtD
Midodrine—Bradycardia—Methylprednisolone—ulcerative colitis	0.00237	0.0028	CcSEcCtD
Midodrine—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00235	0.00277	CcSEcCtD
Midodrine—Feeling abnormal—Azathioprine—ulcerative colitis	0.00224	0.00264	CcSEcCtD
Midodrine—Insomnia—Mesalazine—ulcerative colitis	0.00224	0.00264	CcSEcCtD
Midodrine—Paraesthesia—Mesalazine—ulcerative colitis	0.00223	0.00262	CcSEcCtD
Midodrine—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.00223	0.00262	CcSEcCtD
Midodrine—Dyspnoea—Mesalazine—ulcerative colitis	0.00221	0.0026	CcSEcCtD
Midodrine—Somnolence—Mesalazine—ulcerative colitis	0.00221	0.0026	CcSEcCtD
Midodrine—Asthenia—Budesonide—ulcerative colitis	0.00219	0.00258	CcSEcCtD
Midodrine—Dyspepsia—Mesalazine—ulcerative colitis	0.00218	0.00257	CcSEcCtD
Midodrine—Mental disorder—Hydrocortisone—ulcerative colitis	0.00217	0.00256	CcSEcCtD
Midodrine—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.00216	0.00255	CcSEcCtD
Midodrine—Bradycardia—Betamethasone—ulcerative colitis	0.00216	0.00254	CcSEcCtD
Midodrine—Bradycardia—Dexamethasone—ulcerative colitis	0.00216	0.00254	CcSEcCtD
Midodrine—Pruritus—Budesonide—ulcerative colitis	0.00216	0.00254	CcSEcCtD
Midodrine—Abdominal pain—Azathioprine—ulcerative colitis	0.00215	0.00254	CcSEcCtD
Midodrine—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.00214	0.00252	CcSEcCtD
Midodrine—Pain—Mesalazine—ulcerative colitis	0.00212	0.0025	CcSEcCtD
Midodrine—Angiopathy—Methylprednisolone—ulcerative colitis	0.00212	0.00249	CcSEcCtD
Midodrine—Feeling abnormal—Mesalazine—ulcerative colitis	0.00204	0.00241	CcSEcCtD
Midodrine—Mental disorder—Methylprednisolone—ulcerative colitis	0.00204	0.00241	CcSEcCtD
Midodrine—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.00203	0.00239	CcSEcCtD
Midodrine—Dizziness—Budesonide—ulcerative colitis	0.00202	0.00238	CcSEcCtD
Midodrine—Back pain—Triamcinolone—ulcerative colitis	0.00197	0.00232	CcSEcCtD
Midodrine—Abdominal pain—Mesalazine—ulcerative colitis	0.00196	0.00231	CcSEcCtD
Midodrine—Angiopathy—Dexamethasone—ulcerative colitis	0.00192	0.00227	CcSEcCtD
Midodrine—Angiopathy—Betamethasone—ulcerative colitis	0.00192	0.00227	CcSEcCtD
Midodrine—Rash—Budesonide—ulcerative colitis	0.00192	0.00227	CcSEcCtD
Midodrine—Dermatitis—Budesonide—ulcerative colitis	0.00192	0.00226	CcSEcCtD
Midodrine—Headache—Budesonide—ulcerative colitis	0.00191	0.00225	CcSEcCtD
Midodrine—Hypertension—Prednisolone—ulcerative colitis	0.00191	0.00225	CcSEcCtD
Midodrine—Bradycardia—Prednisone—ulcerative colitis	0.00188	0.00221	CcSEcCtD
Midodrine—Hypertension—Hydrocortisone—ulcerative colitis	0.00187	0.0022	CcSEcCtD
Midodrine—Anxiety—Hydrocortisone—ulcerative colitis	0.00183	0.00216	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00183	0.00215	CcSEcCtD
Midodrine—Nausea—Budesonide—ulcerative colitis	0.00181	0.00213	CcSEcCtD
Midodrine—Dizziness—Azathioprine—ulcerative colitis	0.0018	0.00212	CcSEcCtD
Midodrine—Asthenia—Mesalazine—ulcerative colitis	0.00178	0.0021	CcSEcCtD
Midodrine—Tachycardia—Prednisolone—ulcerative colitis	0.00176	0.00208	CcSEcCtD
Midodrine—Hypertension—Triamcinolone—ulcerative colitis	0.00176	0.00207	CcSEcCtD
Midodrine—Pruritus—Mesalazine—ulcerative colitis	0.00175	0.00207	CcSEcCtD
Midodrine—Hypertension—Methylprednisolone—ulcerative colitis	0.00175	0.00206	CcSEcCtD
Midodrine—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.00173	0.00204	CcSEcCtD
Midodrine—Anxiety—Methylprednisolone—ulcerative colitis	0.00172	0.00203	CcSEcCtD
Midodrine—Tachycardia—Hydrocortisone—ulcerative colitis	0.00172	0.00203	CcSEcCtD
Midodrine—Rash—Azathioprine—ulcerative colitis	0.00172	0.00202	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00172	0.00202	CcSEcCtD
Midodrine—Dermatitis—Azathioprine—ulcerative colitis	0.00172	0.00202	CcSEcCtD
Midodrine—Flushing—Prednisone—ulcerative colitis	0.00171	0.00202	CcSEcCtD
Midodrine—Skin disorder—Hydrocortisone—ulcerative colitis	0.00171	0.00202	CcSEcCtD
Midodrine—Headache—Azathioprine—ulcerative colitis	0.00171	0.00201	CcSEcCtD
Midodrine—Dry mouth—Triamcinolone—ulcerative colitis	0.00169	0.002	CcSEcCtD
Midodrine—Angiopathy—Prednisone—ulcerative colitis	0.00168	0.00197	CcSEcCtD
Midodrine—Confusional state—Methylprednisolone—ulcerative colitis	0.00167	0.00197	CcSEcCtD
Midodrine—Dizziness—Mesalazine—ulcerative colitis	0.00164	0.00193	CcSEcCtD
Midodrine—Insomnia—Prednisolone—ulcerative colitis	0.00163	0.00192	CcSEcCtD
Midodrine—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00163	0.00191	CcSEcCtD
Midodrine—Paraesthesia—Prednisolone—ulcerative colitis	0.00162	0.00191	CcSEcCtD
Midodrine—Tachycardia—Triamcinolone—ulcerative colitis	0.00162	0.00191	CcSEcCtD
Midodrine—Mental disorder—Prednisone—ulcerative colitis	0.00162	0.00191	CcSEcCtD
Midodrine—Nausea—Azathioprine—ulcerative colitis	0.00162	0.00191	CcSEcCtD
Midodrine—Tachycardia—Methylprednisolone—ulcerative colitis	0.00162	0.0019	CcSEcCtD
Midodrine—Skin disorder—Methylprednisolone—ulcerative colitis	0.00161	0.0019	CcSEcCtD
Midodrine—Insomnia—Hydrocortisone—ulcerative colitis	0.0016	0.00188	CcSEcCtD
Midodrine—Hypertension—Betamethasone—ulcerative colitis	0.00159	0.00188	CcSEcCtD
Midodrine—Hypertension—Dexamethasone—ulcerative colitis	0.00159	0.00188	CcSEcCtD
Midodrine—Paraesthesia—Hydrocortisone—ulcerative colitis	0.00158	0.00187	CcSEcCtD
Midodrine—Anxiety—Betamethasone—ulcerative colitis	0.00157	0.00185	CcSEcCtD
Midodrine—Anxiety—Dexamethasone—ulcerative colitis	0.00157	0.00185	CcSEcCtD
Midodrine—Rash—Mesalazine—ulcerative colitis	0.00156	0.00184	CcSEcCtD
Midodrine—Dermatitis—Mesalazine—ulcerative colitis	0.00156	0.00184	CcSEcCtD
Midodrine—Headache—Mesalazine—ulcerative colitis	0.00155	0.00183	CcSEcCtD
Midodrine—Dyspepsia—Hydrocortisone—ulcerative colitis	0.00155	0.00183	CcSEcCtD
Midodrine—Pain—Prednisolone—ulcerative colitis	0.00154	0.00182	CcSEcCtD
Midodrine—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00152	0.00179	CcSEcCtD
Midodrine—Pain—Hydrocortisone—ulcerative colitis	0.00151	0.00178	CcSEcCtD
Midodrine—Insomnia—Triamcinolone—ulcerative colitis	0.0015	0.00177	CcSEcCtD
Midodrine—Insomnia—Methylprednisolone—ulcerative colitis	0.0015	0.00177	CcSEcCtD
Midodrine—Paraesthesia—Triamcinolone—ulcerative colitis	0.00149	0.00176	CcSEcCtD
Midodrine—Feeling abnormal—Prednisolone—ulcerative colitis	0.00149	0.00175	CcSEcCtD
Midodrine—Paraesthesia—Methylprednisolone—ulcerative colitis	0.00149	0.00175	CcSEcCtD
Midodrine—Dyspnoea—Triamcinolone—ulcerative colitis	0.00148	0.00174	CcSEcCtD
Midodrine—Nervous system disorder—Betamethasone—ulcerative colitis	0.00148	0.00174	CcSEcCtD
Midodrine—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00148	0.00174	CcSEcCtD
Midodrine—Agitation—Prednisone—ulcerative colitis	0.00148	0.00174	CcSEcCtD
Midodrine—Nausea—Mesalazine—ulcerative colitis	0.00147	0.00174	CcSEcCtD
Midodrine—Tachycardia—Dexamethasone—ulcerative colitis	0.00147	0.00173	CcSEcCtD
Midodrine—Tachycardia—Betamethasone—ulcerative colitis	0.00147	0.00173	CcSEcCtD
Midodrine—Dyspepsia—Triamcinolone—ulcerative colitis	0.00146	0.00172	CcSEcCtD
Midodrine—Dyspepsia—Methylprednisolone—ulcerative colitis	0.00146	0.00172	CcSEcCtD
Midodrine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00145	0.00171	CcSEcCtD
Midodrine—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00144	0.0017	CcSEcCtD
Midodrine—Pain—Triamcinolone—ulcerative colitis	0.00142	0.00167	CcSEcCtD
Midodrine—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00139	0.00164	CcSEcCtD
Midodrine—Hypertension—Prednisone—ulcerative colitis	0.00139	0.00164	CcSEcCtD
Midodrine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.00137	0.00161	CcSEcCtD
Midodrine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.00137	0.00161	CcSEcCtD
Midodrine—Anxiety—Prednisone—ulcerative colitis	0.00136	0.00161	CcSEcCtD
Midodrine—Insomnia—Betamethasone—ulcerative colitis	0.00136	0.00161	CcSEcCtD
Midodrine—Insomnia—Dexamethasone—ulcerative colitis	0.00136	0.00161	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00136	0.0016	CcSEcCtD
Midodrine—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.00136	0.0016	CcSEcCtD
Midodrine—Paraesthesia—Dexamethasone—ulcerative colitis	0.00135	0.00159	CcSEcCtD
Midodrine—Paraesthesia—Betamethasone—ulcerative colitis	0.00135	0.00159	CcSEcCtD
Midodrine—Dyspepsia—Betamethasone—ulcerative colitis	0.00133	0.00156	CcSEcCtD
Midodrine—Dyspepsia—Dexamethasone—ulcerative colitis	0.00133	0.00156	CcSEcCtD
Midodrine—Abdominal pain—Methylprednisolone—ulcerative colitis	0.00131	0.00154	CcSEcCtD
Midodrine—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.0013	0.00153	CcSEcCtD
Midodrine—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.0013	0.00153	CcSEcCtD
Midodrine—Pain—Betamethasone—ulcerative colitis	0.00129	0.00152	CcSEcCtD
Midodrine—Pain—Dexamethasone—ulcerative colitis	0.00129	0.00152	CcSEcCtD
Midodrine—Nervous system disorder—Prednisone—ulcerative colitis	0.00129	0.00152	CcSEcCtD
Midodrine—Tachycardia—Prednisone—ulcerative colitis	0.00128	0.00151	CcSEcCtD
Midodrine—Skin disorder—Prednisone—ulcerative colitis	0.00127	0.0015	CcSEcCtD
Midodrine—Asthenia—Hydrocortisone—ulcerative colitis	0.00127	0.00149	CcSEcCtD
Midodrine—Pruritus—Hydrocortisone—ulcerative colitis	0.00125	0.00147	CcSEcCtD
Midodrine—Feeling abnormal—Betamethasone—ulcerative colitis	0.00124	0.00146	CcSEcCtD
Midodrine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00124	0.00146	CcSEcCtD
Midodrine—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.00123	0.00145	CcSEcCtD
Midodrine—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.00123	0.00145	CcSEcCtD
Midodrine—Dizziness—Prednisolone—ulcerative colitis	0.00119	0.00141	CcSEcCtD
Midodrine—Asthenia—Triamcinolone—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Midodrine—Abdominal pain—Betamethasone—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Midodrine—Abdominal pain—Dexamethasone—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Midodrine—Asthenia—Methylprednisolone—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Midodrine—Insomnia—Prednisone—ulcerative colitis	0.00119	0.0014	CcSEcCtD
Midodrine—Paraesthesia—Prednisone—ulcerative colitis	0.00118	0.00139	CcSEcCtD
Midodrine—Pruritus—Triamcinolone—ulcerative colitis	0.00117	0.00138	CcSEcCtD
Midodrine—Pruritus—Methylprednisolone—ulcerative colitis	0.00117	0.00138	CcSEcCtD
Midodrine—Dizziness—Hydrocortisone—ulcerative colitis	0.00117	0.00137	CcSEcCtD
Midodrine—Dyspepsia—Prednisone—ulcerative colitis	0.00116	0.00136	CcSEcCtD
Midodrine—Rash—Prednisolone—ulcerative colitis	0.00114	0.00134	CcSEcCtD
Midodrine—Dermatitis—Prednisolone—ulcerative colitis	0.00114	0.00134	CcSEcCtD
Midodrine—Headache—Prednisolone—ulcerative colitis	0.00113	0.00133	CcSEcCtD
Midodrine—Rash—Hydrocortisone—ulcerative colitis	0.00111	0.00131	CcSEcCtD
Midodrine—Dermatitis—Hydrocortisone—ulcerative colitis	0.00111	0.00131	CcSEcCtD
Midodrine—Headache—Hydrocortisone—ulcerative colitis	0.0011	0.0013	CcSEcCtD
Midodrine—Dizziness—Triamcinolone—ulcerative colitis	0.0011	0.00129	CcSEcCtD
Midodrine—Dizziness—Methylprednisolone—ulcerative colitis	0.0011	0.00129	CcSEcCtD
Midodrine—Feeling abnormal—Prednisone—ulcerative colitis	0.00108	0.00127	CcSEcCtD
Midodrine—Asthenia—Dexamethasone—ulcerative colitis	0.00108	0.00127	CcSEcCtD
Midodrine—Asthenia—Betamethasone—ulcerative colitis	0.00108	0.00127	CcSEcCtD
Midodrine—Gastrointestinal pain—Prednisone—ulcerative colitis	0.00107	0.00126	CcSEcCtD
Midodrine—Nausea—Prednisolone—ulcerative colitis	0.00107	0.00126	CcSEcCtD
Midodrine—Pruritus—Dexamethasone—ulcerative colitis	0.00107	0.00126	CcSEcCtD
Midodrine—Pruritus—Betamethasone—ulcerative colitis	0.00107	0.00126	CcSEcCtD
Midodrine—Nausea—Hydrocortisone—ulcerative colitis	0.00105	0.00123	CcSEcCtD
Midodrine—Rash—Triamcinolone—ulcerative colitis	0.00105	0.00123	CcSEcCtD
Midodrine—Dermatitis—Triamcinolone—ulcerative colitis	0.00105	0.00123	CcSEcCtD
Midodrine—Rash—Methylprednisolone—ulcerative colitis	0.00104	0.00123	CcSEcCtD
Midodrine—Dermatitis—Methylprednisolone—ulcerative colitis	0.00104	0.00123	CcSEcCtD
Midodrine—Headache—Triamcinolone—ulcerative colitis	0.00104	0.00123	CcSEcCtD
Midodrine—Headache—Methylprednisolone—ulcerative colitis	0.00104	0.00122	CcSEcCtD
Midodrine—Abdominal pain—Prednisone—ulcerative colitis	0.00104	0.00122	CcSEcCtD
Midodrine—Dizziness—Dexamethasone—ulcerative colitis	0.000996	0.00117	CcSEcCtD
Midodrine—Dizziness—Betamethasone—ulcerative colitis	0.000996	0.00117	CcSEcCtD
Midodrine—Nausea—Triamcinolone—ulcerative colitis	0.000986	0.00116	CcSEcCtD
Midodrine—Nausea—Methylprednisolone—ulcerative colitis	0.000984	0.00116	CcSEcCtD
Midodrine—Rash—Betamethasone—ulcerative colitis	0.00095	0.00112	CcSEcCtD
Midodrine—Rash—Dexamethasone—ulcerative colitis	0.00095	0.00112	CcSEcCtD
Midodrine—Dermatitis—Betamethasone—ulcerative colitis	0.000949	0.00112	CcSEcCtD
Midodrine—Dermatitis—Dexamethasone—ulcerative colitis	0.000949	0.00112	CcSEcCtD
Midodrine—Headache—Dexamethasone—ulcerative colitis	0.000944	0.00111	CcSEcCtD
Midodrine—Headache—Betamethasone—ulcerative colitis	0.000944	0.00111	CcSEcCtD
Midodrine—Asthenia—Prednisone—ulcerative colitis	0.000942	0.00111	CcSEcCtD
Midodrine—Pruritus—Prednisone—ulcerative colitis	0.000928	0.00109	CcSEcCtD
Midodrine—Nausea—Betamethasone—ulcerative colitis	0.000895	0.00105	CcSEcCtD
Midodrine—Nausea—Dexamethasone—ulcerative colitis	0.000895	0.00105	CcSEcCtD
Midodrine—Dizziness—Prednisone—ulcerative colitis	0.000868	0.00102	CcSEcCtD
Midodrine—Rash—Prednisone—ulcerative colitis	0.000827	0.000975	CcSEcCtD
Midodrine—Dermatitis—Prednisone—ulcerative colitis	0.000827	0.000974	CcSEcCtD
Midodrine—Headache—Prednisone—ulcerative colitis	0.000822	0.000968	CcSEcCtD
Midodrine—Nausea—Prednisone—ulcerative colitis	0.000779	0.000918	CcSEcCtD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000606	0.00548	CbGpPWpGaD
Midodrine—ADRA1D—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000594	0.00538	CbGpPWpGaD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.00059	0.00534	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000583	0.00527	CbGpPWpGaD
Midodrine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000574	0.00519	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000573	0.00518	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000571	0.00517	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00057	0.00515	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000551	0.00498	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000531	0.00481	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000519	0.0047	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	0.000509	0.0046	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCR1—ulcerative colitis	0.000505	0.00457	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000503	0.00455	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000502	0.00454	CbGpPWpGaD
Midodrine—ADRA1D—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000501	0.00453	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—RELA—ulcerative colitis	0.000493	0.00446	CbGpPWpGaD
Midodrine—ADRA1B—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000493	0.00446	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.00049	0.00443	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000489	0.00443	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000488	0.00442	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000484	0.00437	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000473	0.00428	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—CXCL8—ulcerative colitis	0.000465	0.00421	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000447	0.00404	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCL20—ulcerative colitis	0.000444	0.00401	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000441	0.00399	CbGpPWpGaD
Midodrine—ADRA1A—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000438	0.00396	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	0.000435	0.00393	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000431	0.0039	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00043	0.00389	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00043	0.00389	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000425	0.00385	CbGpPWpGaD
Midodrine—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000421	0.00381	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—MMP9—ulcerative colitis	0.000421	0.0038	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00042	0.0038	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCR1—ulcerative colitis	0.000419	0.00379	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000416	0.00377	CbGpPWpGaD
Midodrine—ADRA1B—LPA receptor mediated events—NFKB1—ulcerative colitis	0.000416	0.00376	CbGpPWpGaD
Midodrine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000416	0.00376	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000405	0.00367	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCR2—ulcerative colitis	0.000395	0.00358	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000394	0.00356	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000392	0.00354	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000383	0.00346	CbGpPWpGaD
Midodrine—ADRA1D—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00038	0.00344	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCR1—ulcerative colitis	0.000373	0.00337	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCR6—ulcerative colitis	0.000372	0.00336	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00037	0.00335	CbGpPWpGaD
Midodrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	0.000369	0.00334	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCL20—ulcerative colitis	0.000368	0.00333	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00036	0.00326	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000357	0.00323	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCR2—ulcerative colitis	0.000328	0.00297	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—PTGER4—ulcerative colitis	0.000327	0.00296	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCL20—ulcerative colitis	0.000327	0.00296	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000327	0.00295	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000326	0.00295	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000317	0.00287	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000316	0.00285	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCR6—ulcerative colitis	0.000309	0.00279	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	0.000305	0.00276	CbGpPWpGaD
Midodrine—SLC15A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000301	0.00273	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—GHRL—ulcerative colitis	0.0003	0.00271	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCR2—ulcerative colitis	0.000292	0.00264	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00029	0.00262	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000286	0.00258	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00028	0.00254	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCR6—ulcerative colitis	0.000274	0.00248	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—PTGER4—ulcerative colitis	0.000272	0.00246	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00027	0.00245	CbGpPWpGaD
Midodrine—ADRA1B—AMPK Signaling—TP53—ulcerative colitis	0.000269	0.00243	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCR1—ulcerative colitis	0.000259	0.00235	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCL20—ulcerative colitis	0.000251	0.00227	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—GHRL—ulcerative colitis	0.000249	0.00225	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—ADRB2—ulcerative colitis	0.000248	0.00224	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000245	0.00221	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—PTGER4—ulcerative colitis	0.000241	0.00218	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00024	0.00217	CbGpPWpGaD
Midodrine—ADRA1A—AMPK Signaling—TP53—ulcerative colitis	0.000239	0.00216	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000237	0.00214	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—GNA12—ulcerative colitis	0.000236	0.00213	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000233	0.00211	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000228	0.00207	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL20—ulcerative colitis	0.000228	0.00206	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000223	0.00202	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—GHRL—ulcerative colitis	0.000221	0.002	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCR1—ulcerative colitis	0.000215	0.00195	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—GNA12—ulcerative colitis	0.000214	0.00194	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000211	0.0019	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCR6—ulcerative colitis	0.00021	0.0019	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCL20—ulcerative colitis	0.000208	0.00188	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—ADRB2—ulcerative colitis	0.000206	0.00186	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCR2—ulcerative colitis	0.000203	0.00184	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GNA12—ulcerative colitis	0.000196	0.00177	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000193	0.00175	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCR1—ulcerative colitis	0.000191	0.00173	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR6—ulcerative colitis	0.000191	0.00173	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL20—ulcerative colitis	0.000189	0.00171	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SEL1L—ulcerative colitis	0.000186	0.00168	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000185	0.00168	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000185	0.00167	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCL20—ulcerative colitis	0.000185	0.00167	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—ADRB2—ulcerative colitis	0.000183	0.00165	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GNA12—ulcerative colitis	0.000178	0.00161	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR6—ulcerative colitis	0.000174	0.00158	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GNA12—ulcerative colitis	0.000174	0.00157	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000172	0.00155	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—GHRL—ulcerative colitis	0.000169	0.00153	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCR2—ulcerative colitis	0.000168	0.00152	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PTGER4—ulcerative colitis	0.000168	0.00152	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL20—ulcerative colitis	0.000168	0.00152	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000165	0.00149	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR6—ulcerative colitis	0.000158	0.00143	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	0.000158	0.00143	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000157	0.00142	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	0.000155	0.0014	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SEL1L—ulcerative colitis	0.000154	0.0014	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—GHRL—ulcerative colitis	0.000154	0.00139	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000154	0.00139	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCR1—ulcerative colitis	0.000153	0.00139	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	0.000153	0.00139	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	0.00015	0.00135	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CALM3—ulcerative colitis	0.000149	0.00135	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	0.000141	0.00127	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GHRL—ulcerative colitis	0.000141	0.00127	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00014	0.00127	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PTGER4—ulcerative colitis	0.000139	0.00126	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	0.000137	0.00124	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	0.000136	0.00123	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL20—ulcerative colitis	0.000134	0.00122	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000131	0.00118	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GHRL—ulcerative colitis	0.000128	0.00115	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADRB2—ulcerative colitis	0.000127	0.00115	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCR1—ulcerative colitis	0.000127	0.00115	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GNA12—ulcerative colitis	0.000126	0.00114	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CHP1—ulcerative colitis	0.000125	0.00113	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	0.000125	0.00113	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	0.000124	0.00112	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CALM3—ulcerative colitis	0.000124	0.00112	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCR2—ulcerative colitis	0.00012	0.00108	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCL8—ulcerative colitis	0.00012	0.00108	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000119	0.00108	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000119	0.00108	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000116	0.00105	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.000116	0.00105	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	0.000113	0.00103	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	0.000113	0.00102	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR6—ulcerative colitis	0.000113	0.00102	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL20—ulcerative colitis	0.000112	0.00101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	0.00011	0.000993	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADCY5—ulcerative colitis	0.000108	0.000977	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DLD—ulcerative colitis	0.000108	0.000976	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAML2—ulcerative colitis	0.000107	0.000967	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRB2—ulcerative colitis	0.000106	0.000956	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GNA12—ulcerative colitis	0.000105	0.000949	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	0.000103	0.000935	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCR2—ulcerative colitis	9.95e-05	0.0009	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCL8—ulcerative colitis	9.94e-05	0.0009	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTGER4—ulcerative colitis	9.92e-05	0.000898	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	9.92e-05	0.000897	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	9.91e-05	0.000896	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADCY5—ulcerative colitis	9.88e-05	0.000893	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	9.39e-05	0.000849	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR6—ulcerative colitis	9.35e-05	0.000846	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	9.32e-05	0.000843	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GHRL—ulcerative colitis	9.09e-05	0.000822	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADCY5—ulcerative colitis	8.97e-05	0.000811	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAML2—ulcerative colitis	8.87e-05	0.000802	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	8.84e-05	0.000799	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	8.83e-05	0.000799	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CALM3—ulcerative colitis	8.8e-05	0.000796	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	8.8e-05	0.000796	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	8.77e-05	0.000794	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RIPK2—ulcerative colitis	8.67e-05	0.000784	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	8.31e-05	0.000752	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTGER4—ulcerative colitis	8.24e-05	0.000745	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	7.97e-05	0.000721	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	7.88e-05	0.000713	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GHRL—ulcerative colitis	7.54e-05	0.000682	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRB2—ulcerative colitis	7.52e-05	0.00068	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—JAK2—ulcerative colitis	7.42e-05	0.000671	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	7.32e-05	0.000662	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CALM3—ulcerative colitis	7.3e-05	0.000661	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RIPK2—ulcerative colitis	7.19e-05	0.000651	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCL8—ulcerative colitis	6.77e-05	0.000612	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—JAK2—ulcerative colitis	6.74e-05	0.000609	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	6.7e-05	0.000606	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	6.49e-05	0.000587	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—IL2—ulcerative colitis	6.47e-05	0.000585	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	6.39e-05	0.000578	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADCY5—ulcerative colitis	6.38e-05	0.000577	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRB2—ulcerative colitis	6.24e-05	0.000565	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—JAK2—ulcerative colitis	6.16e-05	0.000557	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL8—ulcerative colitis	6.15e-05	0.000556	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL2—ulcerative colitis	5.88e-05	0.000532	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL8—ulcerative colitis	5.62e-05	0.000508	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—JAK2—ulcerative colitis	5.59e-05	0.000506	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	5.54e-05	0.000502	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	5.47e-05	0.000495	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—IL2—ulcerative colitis	5.37e-05	0.000486	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADCY5—ulcerative colitis	5.3e-05	0.000479	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	5.22e-05	0.000472	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL8—ulcerative colitis	5.1e-05	0.000462	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	4.99e-05	0.000452	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	4.97e-05	0.000449	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL2—ulcerative colitis	4.88e-05	0.000441	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	4.77e-05	0.000432	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	4.71e-05	0.000426	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CALM3—ulcerative colitis	4.7e-05	0.000425	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	4.53e-05	0.00041	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	4.33e-05	0.000392	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JAK2—ulcerative colitis	3.98e-05	0.00036	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RELA—ulcerative colitis	3.85e-05	0.000349	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.65e-05	0.00033	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL8—ulcerative colitis	3.63e-05	0.000329	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL2—ulcerative colitis	3.47e-05	0.000314	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—ulcerative colitis	3.45e-05	0.000312	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.41e-05	0.000308	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JAK2—ulcerative colitis	3.3e-05	0.000299	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—ulcerative colitis	3.29e-05	0.000297	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NFKB1—ulcerative colitis	3.25e-05	0.000294	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RELA—ulcerative colitis	3.2e-05	0.000289	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL8—ulcerative colitis	3.01e-05	0.000273	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	2.93e-05	0.000265	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—STAT3—ulcerative colitis	2.92e-05	0.000264	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL2—ulcerative colitis	2.88e-05	0.000261	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—ulcerative colitis	2.87e-05	0.000259	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	2.84e-05	0.000257	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—ulcerative colitis	2.73e-05	0.000247	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—ulcerative colitis	2.71e-05	0.000245	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NFKB1—ulcerative colitis	2.7e-05	0.000244	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	2.68e-05	0.000242	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	2.56e-05	0.000231	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	2.55e-05	0.00023	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.54e-05	0.00023	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STAT3—ulcerative colitis	2.42e-05	0.000219	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	2.42e-05	0.000219	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	2.4e-05	0.000217	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—ulcerative colitis	2.28e-05	0.000207	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—ulcerative colitis	2.25e-05	0.000203	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TP53—ulcerative colitis	2.23e-05	0.000202	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	2.15e-05	0.000195	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—ulcerative colitis	2.04e-05	0.000185	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	2e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TP53—ulcerative colitis	1.85e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—ulcerative colitis	1.69e-05	0.000153	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	1.64e-05	0.000149	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	1.5e-05	0.000136	CbGpPWpGaD
